Renal Biopsy in Type 2 Diabetic Patients
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
The majority of diabetic patients with renal involvement are not biopsied. Studies evaluating histological findings in renal biopsies performed in diabetic patients have shown that approximately one third of the cases will show pure diabetic nephropathy, one third a non-diabetic condition and another third will show diabetic nephropathy with a superimposed disease. Early diagnosis of treatable non-diabetic diseases in diabetic patients is important to ameliorate renal prognosis. The publication of the International Consensus Document for the classification of type 1 and type 2 diabetes has provided common criteria for the classification of diabetic nephropathy and its utility to stratify risk for renal failure has already been demonstrated in different retrospective studies. The availability of new drugs with the potential to modify the natural history of diabetic nephropathy has raised the question whether renal biopsies may allow a better design of clinical trials aimed to delay the progression of chronic kidney disease in diabetic patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971–1993
Gu, K., Cowie, C. C., & Harris, M. I. (1998) · Diabetes Care · doi:10.2337/diacare.21.7.1138 · Cited by 881
Renal and retinal effects of enalapril and losartan in type 1 diabetes
Mauer, M., Zinman, B., Gardiner, R., Suissa, S., Sinaiko, A., Strand, T., Drummond, K., Donnelly, S., Goodyer, P., Gubler, M. C., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808400 · Cited by 791 · cited 2×
“This surrogate of renal inflammation was associated with an increased interstitial volume fraction at five years in females but not in males, pointing out that early inflammation may constitute a risk factor for the progression of histological damage in diabetic patients [36].”
BackgroundKramer, H. J. (2003) · JAMA · doi:10.1001/jama.289.24.3273 · Cited by 618 · cited 1×
“73 m2), one third of patients did not have proteinuria, nor diabetic retinopathy, suggesting that this last group of patients might have suffered from a renal disease different from classical diabetic nephropathy [15].”
BackgroundExcerpts from the US Renal Data System 2009 Annual Data Report
Collins, A. J., Foley, R. N., Herzog, C., Chavers, B. M., Gilbertson, D., Ishani, A., Kasiske, B. L., Liu, J., Mau, L.-W., McBean, M., et al. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.10.009 · Cited by 436 · cited 1×
“Moreover, patient survival in diabetics on maintenance dialysis is lower than in non-diabetic patients with end-stage renal disease due to other renal diseases [6].”
Background
Cited by
Xiang, E., Han, B., Zhang, Q., Rao, W., Wang, Z., Chang, C., Zhang, Y., Tu, C., Li, C., & Wu, D. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01852-y · Cited by 331
Classification and Differential Diagnosis of Diabetic Nephropathy
Qi, C., Mao, X., Zhang, Z., & Wu, H. (2017) · Journal of Diabetes Research · doi:10.1155/2017/8637138 · Cited by 298
Association of metabolic syndrome and chronic kidney disease
Scurt, F. G., Ganz, M. J., Herzog, C., Bose, K., Mertens, P. R., & Chatzikyrkou, C. (2024) · Obesity Reviews · doi:10.1111/obr.13649 · Cited by 155
Nephroprotective effects of GLP-1 receptor agonists: where do we stand?
Mosterd, C. M., Bjornstad, P., & van Raalte, D. H. (2020) · Journal of Nephrology · doi:10.1007/s40620-020-00738-9 · Cited by 56
Zhang, W., Liu, X., Dong, Z., Wang, Q., Pei, Z., Chen, Y., Zheng, Y., Wang, Y., Chen, P., Feng, Z., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.913021 · Cited by 49
Metadata
- Authors
- Espinel, E., Agraz, I., Ibernon, M., Ramos, N., Fort, J., & Serón, D.
- Venue
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Published
- 2015-05-18
- Volume
- 4
- Issue
- 5
- Pages
- 998-1009
- ISSN
- 2077-0383 (ISSN-L)
- OpenAlex
- W2131400831
- Cited by
- 78
- References
- 4
- FWCI
- 3.49
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.